Clinical Trials in Chicago

Showing 18661-18680 of 20,493 trials

CAFE Comparison of Atypicals in First Episode of Psychosis

NCT00034892

The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine (100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder who are experiencing their first psychotic episode.

SchizophreniaPsychotic DisordersMental Health+1 more

AstraZenecaStarted Mar 2002

Stanford, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +23 more locations

COMPLETEDPhase 32.2 miles

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

NCT00090311

The purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate (SEROQUEL) compared with placebo in the treatment of children and adolescent patients with Bipolar I mania.

Bipolar Disorder

AstraZeneca220 participantsStarted Jul 2004

Scottsdale, Arizona, United States • Riverside, California, United States • Sacramento, California, United States +29 more locations

CAFE Comparison of Atypicals in First Episode of Psychosis

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

Find Trials by Condition in Chicago

Iressa Expanded Access Program (EAP)

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.

Assessing and Improving Patient Knowledge About Keloid Scars (Keloids)

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial

Seroquel in Bipolar Depression Versus SSRI

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

S9912 Combination Chemo in Stage III Ovarian Cancer,

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

Study of Antidepressants in Parkinson's Disease

A Study in Erectile Dysfunction

PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)